| __timestamp | Geron Corporation | Jazz Pharmaceuticals plc |
|---|---|---|
| Wednesday, January 1, 2014 | 16758000 | 406114000 |
| Thursday, January 1, 2015 | 17793000 | 449119000 |
| Friday, January 1, 2016 | 18761000 | 502892000 |
| Sunday, January 1, 2017 | 19287000 | 544156000 |
| Monday, January 1, 2018 | 18707000 | 683530000 |
| Tuesday, January 1, 2019 | 20893000 | 736942000 |
| Wednesday, January 1, 2020 | 25678000 | 854233000 |
| Friday, January 1, 2021 | 29665000 | 1451683000 |
| Saturday, January 1, 2022 | 43628000 | 1416967000 |
| Sunday, January 1, 2023 | 69135000 | 1343105000 |
Data in motion
In the competitive world of biopharmaceuticals, managing Selling, General, and Administrative (SG&A) expenses is crucial for maintaining profitability. Jazz Pharmaceuticals plc and Geron Corporation, two prominent players, have shown contrasting approaches over the past decade. From 2014 to 2023, Jazz Pharmaceuticals consistently reported higher SG&A expenses, peaking at approximately $1.45 billion in 2021. This reflects their expansive operations and aggressive market strategies. In contrast, Geron Corporation maintained a more conservative approach, with expenses growing from $16.8 million in 2014 to $69.1 million in 2023, a fourfold increase. While Jazz's expenses are significantly higher, their growth rate is more stable, indicating efficient scaling. Geron's rapid increase suggests a strategic shift or expansion. Understanding these trends offers valuable insights into each company's operational focus and market positioning.
Operational Costs Compared: SG&A Analysis of Merck & Co., Inc. and Geron Corporation
Who Optimizes SG&A Costs Better? Alnylam Pharmaceuticals, Inc. or Jazz Pharmaceuticals plc
Comparing SG&A Expenses: Intra-Cellular Therapies, Inc. vs Geron Corporation Trends and Insights
Breaking Down SG&A Expenses: Dr. Reddy's Laboratories Limited vs Jazz Pharmaceuticals plc
BioMarin Pharmaceutical Inc. and Jazz Pharmaceuticals plc: SG&A Spending Patterns Compared
BioMarin Pharmaceutical Inc. vs Geron Corporation: SG&A Expense Trends
Breaking Down SG&A Expenses: Jazz Pharmaceuticals plc vs Alpine Immune Sciences, Inc.
Jazz Pharmaceuticals plc vs MiMedx Group, Inc.: SG&A Expense Trends
Cost Management Insights: SG&A Expenses for Cytokinetics, Incorporated and Geron Corporation
Cost Management Insights: SG&A Expenses for Veracyte, Inc. and Geron Corporation
Cost Management Insights: SG&A Expenses for ACADIA Pharmaceuticals Inc. and Geron Corporation
Cost Management Insights: SG&A Expenses for MorphoSys AG and Geron Corporation